• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷酸激酶 7 是卵巢癌总生存期的预后指标。

Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.

机构信息

From Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University.

From Cancer Center.

出版信息

Medicine (Baltimore). 2021 Jan 8;100(1):e24134. doi: 10.1097/MD.0000000000024134.

DOI:10.1097/MD.0000000000024134
PMID:33429787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7793326/
Abstract

Ovarian cancer (OC), a common malignant heterogeneous gynecological tumor, is the primary cause of cancer-related death in women worldwide. Adenylate kinase (AK) 7 belongs to the adenylate kinase (AK) family and is a cytosolic isoform of AK. Recent studies have demonstrated that AK7 is expressed in several human diseases, including cancer. However, there is a scarcity of reports on the relationship between AK7 and OC. Here, we compared the expression of AK7 in normal and cancerous ovarian tissues from The Cancer Genome Atlas database and used the c2 test to assess the correlation between AK7 levels and the clinical symptoms of OC. Finally, the prognostic significance of AK7 in OC was determined using the Kaplan-Meier analyses and Cox regression and performed gene set enrichment analysis to detect any relevant signaling pathways. We found that AK7 levels were substantially downregulated in OC than that in normal ovarian tissues (P < .001). Low AK7 levels were related to the patients' age (P = .0093) in OC. The median overall survival (OS) of patients with low AK7-expressing OC was shorter than patients with high AK7-expressing OC (P = .019). The Cox regression analysis (multivariate) identified low AK7 levels were independently related to the prognosis of OC (HR 1.34; P = .048). Our study demonstrated that the downregulated levels of AK7 could serve as an independent prognostic indicator for the OS in OC. Additionally, gene set enrichment analysis revealed that EMT, apical junction, TGF-b signaling, UV response, and myogenesis were associated in the low AK7 expression phenotype (NOM P < .05).

摘要

卵巢癌(OC)是一种常见的恶性异质性妇科肿瘤,是全球女性癌症相关死亡的主要原因。腺苷酸激酶(AK)7 属于腺苷酸激酶(AK)家族,是 AK 的细胞质同工酶。最近的研究表明,AK7 在包括癌症在内的几种人类疾病中表达。然而,关于 AK7 与 OC 的关系的报道很少。在这里,我们比较了来自癌症基因组图谱数据库的正常和癌性卵巢组织中 AK7 的表达,并使用 c2 检验评估 AK7 水平与 OC 临床症状之间的相关性。最后,使用 Kaplan-Meier 分析和 Cox 回归确定 AK7 在 OC 中的预后意义,并进行基因集富集分析以检测任何相关的信号通路。我们发现,AK7 在 OC 中的表达水平明显低于正常卵巢组织(P<0.001)。在 OC 中,低 AK7 水平与患者的年龄有关(P=0.0093)。低 AK7 表达 OC 患者的中位总生存期(OS)短于高 AK7 表达 OC 患者(P=0.019)。Cox 回归分析(多变量)确定低 AK7 水平与 OC 的预后独立相关(HR 1.34;P=0.048)。我们的研究表明,AK7 水平的下调可作为 OC OS 的独立预后指标。此外,基因集富集分析表明,EMT、顶端连接、TGF-b 信号、UV 反应和肌生成与低 AK7 表达表型相关(NOM P<0.05)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/ecebff4edffc/medi-100-e24134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/d6576572c039/medi-100-e24134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/d30d3f6d93de/medi-100-e24134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/ecebff4edffc/medi-100-e24134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/d6576572c039/medi-100-e24134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/d30d3f6d93de/medi-100-e24134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb02/7793326/ecebff4edffc/medi-100-e24134-g003.jpg

相似文献

1
Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.腺苷酸激酶 7 是卵巢癌总生存期的预后指标。
Medicine (Baltimore). 2021 Jan 8;100(1):e24134. doi: 10.1097/MD.0000000000024134.
2
ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.ATP结合盒亚家族B成员9(ABCB9)是卵巢癌总生存期的一个预后指标。
Medicine (Baltimore). 2019 May;98(19):e15698. doi: 10.1097/MD.0000000000015698.
3
Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.ALDH5A1表达降低可预测卵巢癌患者的预后。
Cancer Biol Ther. 2017 Apr 3;18(4):245-251. doi: 10.1080/15384047.2017.1295175. Epub 2017 Mar 27.
4
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.鉴定和验证一个与 m6A 相关的七个长链非编码 RNA 标志物,用于预测卵巢癌的预后。
BMC Cancer. 2022 Jun 8;22(1):633. doi: 10.1186/s12885-022-09591-4.
5
A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.一种基于共表达网络分析和五种长链非编码RNA表达水平的新型卵巢癌风险评分系统。
BMC Med Genet. 2019 Jun 10;20(1):103. doi: 10.1186/s12881-019-0832-9.
6
[Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].[层粘连蛋白γ3(LAMC3)降低与卵巢癌预后不良的关系]
Zhonghua Fu Chan Ke Za Zhi. 2021 Jul 25;56(7):489-497. doi: 10.3760/cma.j.cn112141-20210426-00230.
7
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.用于筛选卵巢癌关键预后基因的生物信息学分析
J Ovarian Res. 2017 Apr 13;10(1):27. doi: 10.1186/s13048-017-0323-6.
8
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
9
A retrospective analysis of immunohistochemically determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients.对连续 114 例卵巢癌患者的免疫组织化学检测的 IRF4(干扰素调节因子 4)表达进行回顾性分析。
Arch Gynecol Obstet. 2019 Jan;299(1):239-246. doi: 10.1007/s00404-018-4941-z. Epub 2018 Oct 24.
10
Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.全面分析层粘连蛋白基因在卵巢癌中的表达和预后。
Pathol Oncol Res. 2021 Aug 25;27:1609855. doi: 10.3389/pore.2021.1609855. eCollection 2021.

引用本文的文献

1
A novel cuproptosis-related genes nomogram on the prognosis and immune microenvironment of breast invasive carcinoma.一种关于乳腺浸润性癌预后和免疫微环境的新型铜死亡相关基因列线图。
Sci Rep. 2025 Aug 5;15(1):28643. doi: 10.1038/s41598-025-14621-9.
2
Identification of molecular subtypes and a prognostic signature based on machine learning and purine metabolism-related genes in breast cancer.基于机器学习和嘌呤代谢相关基因的乳腺癌分子亚型鉴定及预后特征分析
Medicine (Baltimore). 2025 May 23;104(21):e42288. doi: 10.1097/MD.0000000000042288.
3
AK7-deficiency reversal inhibits ccRCC progression and boosts anti-PD1 immunotherapy sensitivity.
AK7 缺乏逆转抑制 ccRCC 进展并增强抗 PD-1 免疫治疗敏感性。
Aging (Albany NY). 2024 Jul 5;16(13):11072-11089. doi: 10.18632/aging.206006.
4
Targeting purine metabolism in ovarian cancer.靶向卵巢癌中的嘌呤代谢。
J Ovarian Res. 2022 Aug 13;15(1):93. doi: 10.1186/s13048-022-01022-z.
5
Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.系统分析卵巢癌预后与可变剪接的关系。
J Ovarian Res. 2021 Sep 15;14(1):120. doi: 10.1186/s13048-021-00866-1.
6
Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.卵巢癌预后因素及生物标志物的研究进展
J Cancer. 2021 May 13;12(13):3976-3996. doi: 10.7150/jca.47695. eCollection 2021.